Search Results 361-370 of 1178 for ai制作网格,ai翻唱网站,ai 写作网,ai工具合集官网,ai编歌网站,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat

  1. Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

    Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck · Overview · Participation ...

  2. A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM) - Mayo Clinic

    This study is to evaluate the safety, efficacy and clinical benefit of BGB-3111 vs ibrutinib in subjects with MYD88 Mutation Waldenström's Macroglobulinemia.

  3. Santiago Restrepo Castillo: Developing New Gene Editing Techniques to Cure Disease - Student Research - Mayo Clinic College of Medicine & Science

    Santiago Restrepo Castillo, Ph.D. student in virology and gene therapy at Mayo Clinic, shares research on new gene editing techniques to cure disease.

  4. Past Lab Members - Mayo Clinic Research

    View past members of Mayo Clinic's Bone Injury and Repair Lab led by Abhishek Chandra, Ph.D., M.S..

  5. About - Genetics of Alzheimer's Disease and Endophenotypes Laboratory - Mayo Clinic Research

    Learn about Dr. Nilufer Ertekin-Taner, her research, and faculty and staff in the Genetics of Alzheimer's Disease and Endophenotypes lab at Mayo Clinic.

  6. Neural Regenerative Research - Our Research

    The Neural Regenerative Research Lab of Alexander Y. Shin, M.D., at Mayo Clinic studies peripheral motor nerve regeneration of nerve autografts and ...

  7. Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

    Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck · Overview · Participation eligibility.

  8. Study of SC-003 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer - Mayo Clinic

    SC-003 is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody linked to a potent chemotherapy. Participation eligibility. Participant ...

  9. A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer (MOUNTAINEER-03) - Mayo Clinic

    The purpose of this study is to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive ...

  10. Education - Mayo Clinic Research

    D. or M.D.-Ph.D. program. Participants receive stipends to cover their expenses. Summer Undergraduate Research Fellowship (SURF). This is a 10-week research ...